0001493152-22-006625.txt : 20220311
0001493152-22-006625.hdr.sgml : 20220311
20220311161533
ACCESSION NUMBER: 0001493152-22-006625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220310
FILED AS OF DATE: 20220311
DATE AS OF CHANGE: 20220311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gottschalk Emily
CENTRAL INDEX KEY: 0001791108
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37492
FILM NUMBER: 22733312
MAIL ADDRESS:
STREET 1: 3150 ALMADEN EXPRESSWAY
STREET 2: SUITE 250
CITY: SAN JOSE
STATE: CA
ZIP: 95118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anixa Biosciences Inc
CENTRAL INDEX KEY: 0000715446
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 112622630
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250
CITY: SAN JOSE
STATE: CA
ZIP: 95118
BUSINESS PHONE: 408-708-9808
MAIL ADDRESS:
STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250
CITY: SAN JOSE
STATE: CA
ZIP: 95118
FORMER COMPANY:
FORMER CONFORMED NAME: ITUS Corp
DATE OF NAME CHANGE: 20140902
FORMER COMPANY:
FORMER CONFORMED NAME: COPYTELE INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2022-03-10
0
0000715446
Anixa Biosciences Inc
ANIX
0001791108
Gottschalk Emily
C/O ANIXA BIOSCIENCES, INC.
3150 ALMADEN EXPRESSWAY, SUITE 250
SAN JOSE,
CA
95118
1
0
0
0
Employee Stock Option (Right to Buy)
2.74
2022-03-10
4
A
0
100000
0
A
2032-03-10
Common Stock
100000
100000
D
Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
The options vest and become exercisable in twelve (12) equal monthly installments beginning March 31, 2022.
/s/ Emily Gottschalk
2022-03-11